Hofseth Biocare ASA: HBC receive additional food s

Hofseth BioCare ASA (HBC) has received the Food Safety System Certification 22000 (FSSC 22000), which is an ISO-based certification scheme for auditing and certification of food safety systems in the food supply chain. The FSSC 22000 certification scheme is fully recognised and accepted by the Global Food Safety Initiative (GFSI) and by the European co-operation for Accreditation (EA).

After recently completing the expansion work and recommencement of production at the Midsund plant, the FSSC 22000 standard will further secure the high-quality production of marine ingredients at HBC from 2017.

HBC has during the fourth quarter been granted patents on ProGo® and OmeGo® in several important markets, including Spain, Ireland, United Kingdom, Netherlands, Switzerland, Belgium and Germany. The patent grants for "Compositions and Methods for Increasing Iron Absorption" on ProGo®, gives HBC the sole marketing claim rights to for increasing iron uptake in humans from marine protein sources in these important markets.

From January 2017, Karl Inge Slotsvik joins HBC as new COO. Mr Slotsvik, 35, previously held several positions in Firmenich Bjørge Biomarin AS, such as Production Manager, General Manager and most recently Global Innovation and Business Development Director.

• We are delighted that Karl Inge, with his extensive experience and contact network, decided to join HBC. He will be a key person in our ongoing process of streamlining production and logistics, and a crucial element in the further strengthening of our sales organization and market reach, says Hofseth BioCare CEO, Tor Erik Andersen.

For further information, please contact:

Tor Erik Andersen, CEO of Hofseth BioCare ASA Mob: +47 911 79 854 E-mail: tea@hofsethbiocare.no

Jon Olav Ødegård, CFO of Hofseth BioCare ASA Phone: +47 936 32 966 E-mail: joo@hofsethbiocare.no

About Hofseth BioCare ASA:

HBC is a Norwegian biotech company that offers high-value ingredients and finished products for humans and pets. The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources. Through an innovative hydrolysis technology, HBC is able to preserve the quality of salmon oil, proteins and calcium, prepared of fresh salmon off-cuts. HBC's objective is to contribute to the efficient use of marine resources and deliver quality products for ingredients and finished consumer products in the nutrition market.

Hofseth BioCare's headquarters are located in Ålesund, Norway with branches in Oslo, Chicago, Mumbai and Tokyo. HBC is listed on Oslo Stock Exchange Axess list with ticker "HBC". More information about Hofseth BioCare at www.hofsethbiocare.com and www.facebook.com/hofsethbiocare This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.